CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
36.99
-1.05 (-2.76%)
At close: Mar 28, 2025, 4:00 PM
35.44
-1.55 (-4.19%)
Pre-market: Mar 31, 2025, 8:53 AM EDT
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $3.17 billion as of March 31, 2025. Its market cap has decreased by -47.15% in one year.
Market Cap
3.17B
Enterprise Value
1.49B
1-Year Change
-47.15%
Ranking
Category
Stock Price
$36.99
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $3.17B, an increase of 466.47%. That is a compound annual growth rate of 22.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 3.17B | -5.56% |
Dec 31, 2024 | 3.36B | -32.44% |
Dec 29, 2023 | 4.97B | 56.24% |
Dec 30, 2022 | 3.18B | -45.12% |
Dec 31, 2021 | 5.80B | -46.39% |
Dec 31, 2020 | 10.82B | 221.74% |
Dec 31, 2019 | 3.36B | 126.76% |
Dec 31, 2018 | 1.48B | 53.95% |
Dec 29, 2017 | 963.10M | 19.42% |
Dec 30, 2016 | 806.50M | 43.99% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |